CLINICAL STUDIES ON SULTAMICILLIN FINE GRANULES IN THE UROLOGICAL FIELD
Clinical studies of sultamicillin (SBTPC) fine granules, an oral antibiotic with ester linked ampicillin and β-lactamase inhibitor, sulbactam, were performed in acute uncomplicated cystitis and complicated urinary tract infections. 1. SBTPC fine granules were administrated at a dose of 187.5mg 2-3 t...
Saved in:
Published in | Japanese journal of antibiotics Vol. 41; no. 12; pp. 2044 - 2058 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
Japan
Japan Antibiotics Research Association
01.12.1988
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Clinical studies of sultamicillin (SBTPC) fine granules, an oral antibiotic with ester linked ampicillin and β-lactamase inhibitor, sulbactam, were performed in acute uncomplicated cystitis and complicated urinary tract infections. 1. SBTPC fine granules were administrated at a dose of 187.5mg 2-3 times daily for 5-7days to 6 patients with acute uncomplicated cystitis. Clinical emcacies as judged according to the criteria of the UTI Committee were excellent in 5 cases and moderate in 1 case with an effectiveness rate of 100%. All of 7 identified bacteria were eradicated by the treatment. 2. SBTPC fine granules were administrated at a dose of 187.5mg or 375mg 3 times daily for 5-7 days to 17 patients with complicated urinary tract infections. Clinical efficacies as judged according to the criteria of the UTI Committee were excellent in 8 cases, moderate in 4 cases and poor in 5 cases with an effectiveness rate of 70.6%. Out of 17 identified bacteria, 14 (82.4%) were eradicated by the treatment. 3. As adverse reactions, glossitis, diarrhea and pharyngeal redness were observed in 1 case out of 31 cases treated with the drug. These symptoms, however, were mild and transient. No abnormal laboratory test values were observed. From the above results, it appears that SBTPC fine granules are useful in the treatment of urinary tract infections. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0368-2781 2186-5477 |
DOI: | 10.11553/antibiotics1968b.41.2044 |